help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castro, M.
Right arrow Articles by Moreira, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castro, M.
Right arrow Articles by Moreira, A. C.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 3 878-882
Copyright © 1999 by The Endocrine Society

Original Studies

Out-Patient Screening for Cushing’s Syndrome: The Sensitivity of the Combination of Circadian Rhythm and Overnight Dexamethasone Suppression Salivary Cortisol Tests1

Margaret Castro, Paula C. L. Elias, Ana R. P. Quidute, Fernanda P. B. Halah and Ayrton C. Moreira

Endocrinology Division, Department of Medicine and Department of Physiology, Faculty of Medicine, 14049–900 Ribeirao Preto, Sao Paulo, Brazil

Address all correspondence and requests for reprints to: Ayrton C. Moreira, M.D., Department of Medicine, Faculty of Medicine, 14049–900 Ribeirao Preto, Sao Paulo, Brazil.

Screening tests have been used to support a biochemical diagnosis of Cushing’s syndrome (CS). Measurements of salivary cortisol offer facilities for studying out-patients. This study assessed salivary cortisol in screening for CS by evaluating hypercortisolism based on circadian rhythm and the overnight 1-mg dexamethasone (DEX) suppression test for out-patients. We evaluated 33 patients with CS. Thirty normal volunteers and 18 obese patients were used as controls. Salivary cortisol (nanograms per dL) levels (mean ± SEM) were 596 ± 44, 528 ± 104, and 1205 ± 118 (0900 h); 213 ± 27, 325 ± 76, and 778 ± 74 (1700 h); and 95 ± 8, 133 ± 26, and 914 ± 94 (2300 h) in normal controls, obese subjects, and CS patients, respectively. After the overnight 1-mg DEX test, they were 64 ± 1.1, 107 ± 25, and 1048 ± 129, respectively. In the present series, a single out-patient 0900, 1700, and 2300 h measurement and an overnight 1-mg DEX salivary cortisol level above the 90th percentile of the control or obese group values had sensitivities of 65.6%, 81.8%, 100%, and 100% or 78.1%, 57.6%, 93.3%, and 91.4%, respectively. The sensitivity improved (100%) in response to the combination of 2300 h and overnight 1-mg DEX salivary cortisol suppression tests to differentiate between obese and CS subjects. Our data indicate that nighttime sample and overnight 1-mg DEX suppression salivary cortisol tests are sensitive markers for the diagnosis of CS. In addition, the combination of the two tests improves the ability to differentiate between obese and CS patients and may be useful for out-patient screening.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Carneiro, S. M. Togeiro, L. F. Hayashi, F. F. Ribeiro-Filho, A. B. Ribeiro, S. Tufik, and M. T. Zanella
Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E380 - E384.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. K. Nieman, B. M. K. Biller, J. W. Findling, J. Newell-Price, M. O. Savage, P. M. Stewart, and V. M. Montori
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1526 - 1540.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. Kidambi, H. Raff, and J. W Findling
Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome
Eur. J. Endocrinol., December 1, 2007; 157(6): 725 - 731.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. H. Golden, S. Malhotra, G. S. Wand, F. L. Brancati, D. Ford, and K. Horton
Adrenal Gland Volume and Dexamethasone-Suppressed Cortisol Correlate with Total Daily Salivary Cortisol in African-American Women
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1358 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. Findling and H. Raff
Cushing's Syndrome: Important Issues in Diagnosis and Management
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3746 - 3753.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
G. Reimondo, B. Allasino, S. Bovio, P. Paccotti, A. Angeli, and M. Terzolo
Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome
Eur. J. Endocrinol., December 1, 2005; 153(6): 803 - 809.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro
Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Viardot, P. Huber, J. J. Puder, H. Zulewski, U. Keller, and B. Muller
Reproducibility of Nighttime Salivary Cortisol and Its Use in the Diagnosis of Hypercortisolism Compared with Urinary Free Cortisol and Overnight Dexamethasone Suppression Test
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5730 - 5736.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Yaneva, H. Mosnier-Pudar, M.-A. Dugue, S. Grabar, Y. Fulla, and X. Bertagna
Midnight Salivary Cortisol for the Initial Diagnosis of Cushing's Syndrome of Various Causes
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3345 - 3351.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Putignano, P. Toja, A. Dubini, F. P. Giraldi, S. M. Corsello, and F. Cavagnini
Midnight Salivary Cortisol Versus Urinary Free and Midnight Serum Cortisol as Screening Tests for Cushing's Syndrome
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4153 - 4157.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
H. Raff and J. W. Findling
A Physiologic Approach to Diagnosis of the Cushing Syndrome
Ann Intern Med, June 17, 2003; 138(12): 980 - 991.
[Full Text] [PDF]

Home page
 Biol Res NursHome page
S. L. King and K. M. Hegadoren
Stress Hormones: How Do They Measure Up?
Biol Res Nurs, October 1, 2002; 4(2): 92 - 103.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. A. Papanicolaou, N. Mullen, I. Kyrou, and L. K. Nieman
Nighttime Salivary Cortisol: A Useful Test for the Diagnosis of Cushing's Syndrome
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4515 - 4521.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Moro, P. Putignano, M. Losa, C. Invitti, C. Maraschini, and F. Cavagnini
The Desmopressin Test in the Differential Diagnosis between Cushing's Disease and Pseudo-Cushing States
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3569 - 3574.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society